AMGN vs PFE
By Alex · Tickerpine
Amgen Inc. vs Pfizer, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | PFE |
|---|---|---|
| Price | $416.18 | $26.31 |
| Market cap | $225.15B | $149.96B |
| P/E ratio | 25.7 | 35.1 |
| ROE | 91.47% | 5.01% |
| Profit margin | 22.95% | 6.80% |
| Revenue growth | 9.50% | 2.60% |
| Dividend yield | 2.43% | 6.46% |
| Beta | 0.41 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs PFE in plain English
- AMGN is the bigger company — about 1.5× the market cap of PFE.
- AMGN is cheaper on earnings (P/E 25.7 vs 35.1).
- AMGN earns a higher return on equity (91% vs 5%).
- AMGN is growing revenue faster (10% vs 3%).
- PFE has the higher dividend yield (6.46% vs 2.43%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
PFE return calculator
See what $1,000 in Pfizer, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.